MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,142,497 | -2.0% | 186,926 | -18.7% | 0.00% | 0.0% |
Q2 2023 | $8,305,673 | +49.8% | 229,883 | +54.2% | 0.00% | +50.0% |
Q1 2023 | $5,544,579 | -35.7% | 149,128 | -21.6% | 0.00% | -50.0% |
Q4 2022 | $8,618,869 | +297.7% | 190,220 | +513.0% | 0.00% | +300.0% |
Q3 2022 | $2,167,000 | -61.9% | 31,032 | -63.3% | 0.00% | -50.0% |
Q2 2022 | $5,682,000 | -60.7% | 84,646 | -51.9% | 0.00% | -60.0% |
Q1 2022 | $14,476,000 | -23.1% | 176,057 | +37.3% | 0.01% | -16.7% |
Q4 2021 | $18,814,000 | -24.2% | 128,258 | -8.6% | 0.01% | -25.0% |
Q3 2021 | $24,812,000 | +31.1% | 140,252 | +19.7% | 0.01% | +14.3% |
Q2 2021 | $18,932,000 | +135.4% | 117,204 | +149.6% | 0.01% | +133.3% |
Q1 2021 | $8,044,000 | -41.7% | 46,956 | -25.2% | 0.00% | -57.1% |
Q4 2020 | $13,797,000 | -25.6% | 62,817 | -43.7% | 0.01% | -36.4% |
Q3 2020 | $18,539,000 | +350.7% | 111,644 | +209.9% | 0.01% | +266.7% |
Q2 2020 | $4,113,000 | -10.1% | 36,021 | -39.5% | 0.00% | -25.0% |
Q1 2020 | $4,574,000 | +288.9% | 59,500 | +552.1% | 0.00% | +100.0% |
Q4 2019 | $1,176,000 | +6.0% | 9,124 | -35.9% | 0.00% | 0.0% |
Q3 2019 | $1,109,000 | +233.0% | 14,238 | +101.5% | 0.00% | +100.0% |
Q3 2018 | $333,000 | -50.1% | 7,067 | -87.6% | 0.00% | -50.0% |
Q3 2017 | $668,000 | +40.0% | 57,127 | +312.1% | 0.00% | -33.3% |
Q3 2015 | $477,000 | +95.5% | 13,863 | +13.6% | 0.00% | 0.0% |
Q2 2014 | $244,000 | +15.6% | 12,201 | +10.1% | 0.00% | +50.0% |
Q1 2014 | $211,000 | – | 11,080 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |